ΠΠ·Π°ΠΈΠΌΠΎΠ΄Π΅ΠΉΡΡΠ²ΠΈΠ΅ ΠΎΠ½ΠΊΠΎΠ³Π΅Π½ΠΎΠ² ΠΈ ΡΠ΅Π³ΡΠ»ΡΡΠΎΡΠ½ΡΡ Π³Π΅Π½ΠΎΠ² Π² ΠΊΠ»Π΅ΡΠΊΠ°Ρ , ΡΡΠ°Π½ΡΡΠΎΡΠΌΠΈΡΠΎΠ²Π°Π½Π½ΡΡ Π²ΠΈΡΡΡΠΎΠΌ ΡΠ°ΡΠΊΠΎΠΌΡ Π Π°ΡΡΠ°
ΠΠΈΡΡΠ΅ΡΡΠ°ΡΠΈΡ
ΠΡΠ»Π° ΠΏΡΠ΅Π΄ΠΏΡΠΈΠ½ΡΡΠ° ΠΏΠΎΠΏΡΡΠΊΠ° ΠΈΠ·ΠΌΠ΅Π½ΠΈΡΡ ΠΌΠ΅ΡΠ°ΡΡΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΡΠ²ΠΎΠΉΡΡΠ²Π° ΡΡΠ°Π½ΡΡΠΎΡΠΌΠΈΡΠΎΠ²Π°Π½Π½ΡΡ v-src ΠΊΠ»Π΅ΡΠΎΠΊ ΠΏΡΡΠ΅ΠΌ Π²Π²Π΅Π΄Π΅Π½ΠΈΡ Π² Π½ΠΈΡ ΠΎΠ½ΠΊΠΎΠ³Π΅Π½Π° Π΄ΡΡΠ³ΠΎΠ³ΠΎ ΡΠ΅ΠΌΠ΅ΠΉΡΡΠ²Π° — N-ras. ΠΠ½ΠΊΠΎΠ³Π΅Π½Ρ N-ras ΠΈ v-src ΠΎΡΠ½ΠΎΡΡΡΡΡ ΠΊ ΡΠ°Π·Π»ΠΈΡΠ½ΡΠΌ ΠΊΠ»Π°ΡΡΠ°ΠΌ. ΠΠ±Π° ΡΡΠΈ ΠΎΠ½ΠΊΠΎΠ³Π΅Π½Π° ΠΈΠ·Π²Π΅ΡΡΠ½Ρ ΡΠ²ΠΎΠ΅ΠΉ ΡΠΏΠΎΡΠΎΠ±Π½ΠΎΡΡΡΡ ΠΊ ΡΡΠ°Π½ΡΡΠΎΡΠΌΠ°ΡΠΈΠΈ in vivo ΠΈ in vitro, Π° ΡΠ°ΠΊΠΆΠ΅ ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΠ΅ΠΉ Π² ΠΎΠΏΡΡ ΠΎΠ»ΡΡ ΡΠ°Π·Π»ΠΈΡΠ½ΠΎΠ³ΠΎ ΠΏΡΠΎΠΈΡΡ ΠΎΠΆΠ΄Π΅Π½ΠΈΡ. Π ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ΅ Π±ΡΠ» ΠΏΠΎΠ»ΡΡΠ΅Π½ ΡΡΠ΄ Π»ΠΈΠ½ΠΈΠΉ ΠΊΠ»Π΅ΡΠΎΠΊ, ΠΊΠΎΡΠΎΡΡΠ΅ ΡΠ²Π»ΡΡΡΡΡ… Π§ΠΈΡΠ°ΡΡ Π΅ΡΡ >
Π‘ΠΏΠΈΡΠΎΠΊ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ
- ΠΠ»Π±Π΅ΡΡΡ Π., ΠΡΠ΅ΠΉ Π., ΠΡΡΠΈΡ ΠΠΆ., Π ΡΡΡ Π., Π ΠΎΠ±Π΅ΡΡΠ΅ Π., Π£ΠΎΡΡΠΎΠ½ ΠΠΆ. ΠΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½Π°Ρ Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡ ΠΊΠ»Π΅ΡΠΊΠΈ. Π’. 2. Π., «ΠΠΈΡ», 1994, 359−371.
- ΠΡΠ°ΡΠΈΡΠΊΠΈΡΠ΅ Π.Π., Π.Π. Π’Π°ΡΠΎΡΡΠ½, Π€. Π. ΠΠΈΡΠ΅Π»Π΅Π², Π.Π, ΠΠ°ΡΠ»Π΅Π²Π°, Π. Π. ΠΠ΅ΠΉΡΠΌΠ°Π½ Π Π°Π·Π»ΠΈΡΠΈΡ Π² ΡΠ°ΡΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠΈ ΠΏΡΠΎΠ²ΠΈΡΡΡΠΎΠ² Π² Π½ΠΈΠ·ΠΊΠΎ- ΠΈ Π²ΡΡΠΎΠΊΠΎΠΌΠ΅ΡΠ°ΡΡΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΡ Π²Π°ΡΠΈΠ°Π½ΡΠ°Ρ ΠΊΠ»Π΅ΡΠΎΠΊ Ρ ΠΎΠΌΡΠΊΠΎΠ², ΡΡΠ°Π½ΡΡΠΎΡΠΌΠΈΡΠΎΠ²Π°Π½Π½ΡΡ Π²ΠΈΡΡΡΠΎΠΌ ΡΠ°ΡΠΊΠΎΠΌΡ Π Π°ΡΡΠ°. ΠΠΎΠ».Π±ΠΈΠΎΠ»., 1989, 23.
- ΠΠ΅Π½Π½ΠΈΡ Π . «ΠΠΈΠΎΠΌΠ΅ΠΌΠ±ΡΠ°Π½Ρ». Π., «ΠΠΈΡ», 1997
- Abo A, Pick Π, Hall A, Totty N, Teahan CG, Segal AW — Activation of the NADPH oxidase involves the small GTP-binding protein p21 rac 1. Nature, 1991,353,668−70.
- Aftab DT, Kwan J, Martin GS. Ras-independent transformation by v-Src. Proc Natl Acad Sci USA. 1997, 7, 3028−33.
- Blom N, Gammeltoft S and Brunak S. Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J. Mol.Biol., 1999, 294, 1351
- Bolen J. Nonreceptor tyrosine proteine kinases. Oncogerxi, 1993, 8, 20 252 031.
- Bowman T, Garcia R, Turkson J, Jove R. STATs in oncogenesis. Oncogene. 2000, 19(21), 2474−88.
- Bromberg JF, Horvath CM, Besser D, Lathem WW, Darnell JE Jr. Stat3 activation is required for cellular transformation by v-src. Mol Cell Biol, 1998, 18,2553−8.
- Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C, Darnell JE Jr. Stat3 as an oncogene. Cell, 1999, 98(3), 295−303.
- Brown MT, Cooper JA. Regulation, substrates and functions of src. Biochim BiophysActa, 1996, 1287(2−3), 121−49.
- Brugge JS, Erikson RL. Identification of a transformation-specific antigen induced by an avian sarcoma virus. Nature, 1977, 269, 346−8.
- Buss JE, Kamps MP, Gould K, Sefton BM. The absence of myristic acid decreases membrane binding of p60src but does not affect tyrosine protein kinase activity. J Virol., 1986, 58, 468−74.
- Chackalaparampil I, Shalloway D. Altered phosphorylation and activation of pp60c-src during fibroblast mitosis. Cell, 1988, 52, 801−10.
- Chant J, Corrado K, Pringle JR, Herskowitz I. Yeast BUD5, encoding a putative GDP-GTP exchange factor, is necessary for bud site selection and interacts with bud formation gene BEM1. Cell, 1991, 65, 1213−24.
- Cicchetti P, Mayer Π J, Thiel G, Baltimore D. Identification of a protein that binds to the SH3 region of Abl and is similar to Bcr and GAP-rho. Science, 1992, 257, 803−6.
- Collett MS, Brugge JS, Erikson RL. Characterization of a normal avian cell protein related to the avian sarcoma virus transforming gene product. Cell, 1978, 15, 1363−9.
- Cooper JA and Howell B. The when and how of Src regulation. Cel, 1993, 73, 1051−1054.
- Cooper JA, Esch FS, Taylor SS, Hunter T. Phosphorylation sites in enolase and lactate dehygrogenaze utilized by tyrosine protein kinases in vivo and in vitro. J. Biol. Chem, 1984, 259, 7835−41.
- Cooper JA, Gould KL, Cartwright CA, Hunte T. Tyrosine 527 is phosphorylated in pp60Β°"src: implications for regulation. Science, 1986, 231,1431.1434.
- Cotton PC and Brugge JS. Neural tissues express high levels of the cellular src gene product pp60c-src. Mol.Cell. Biol. 1983, 3, 1157−1162,
- Courtneidge SA. Activation of pp60c"src kinase by middle T antigene binding or by dephosphorylation. EMBO J. 1985, 4, 1471−77.
- Courtneidge SA, Dhand R, Pilat D, Twamley GM, Waterfield MD, Roussel MF. Activation of src-family kinases by CSF-1, and their association with its receptor. EMBO J., 1993, 12, 943−950.
- Crawford DR, Scools G, Salmon S, Davies K. Hydrogen peroxide induces the expression of adaptl5, a novel RNA associated with polysomes in hamster HA-1 cells. Arch Biochem Biophys., 1996, 325,256−64.
- Cross FR, Garber EA, Hanafusa H. N-terminal deletions in Rous sarcoma virus p60src: effects on tyrosine kinase and biological activities and on recombination in tissue culture with cellular src gene. Moll. Cell. Biol., 1985, 5, 2789−95
- Cross FR, Garber EA, Pellman D, Hanafusa H. A short sequence in the p60src N terminus is required for p60src myristylation and membrane association and for cell transformation. Moll. Cell. Biol., 1984, 4, 1834−42.
- DeClue JE, Martin GS. Linker insertion-deletion mutagenesis of the v-src gene: isolation of host- and temperature-dependent mutants. J Virol. 1989, 63(2), 542−54.-
- Deichman GI, Kashkina LM, Mizenina OA, Gorojanskaya EG, Nikiforov MA, Gudkov AV, Dyakova NA, Komelkov AV, Prilutskaya MO, Kushlinsky NE and Tatosyan AG. Int. J. Cancer, 1996, 66, 747−752.
- Dennis EA. Regulation of eicosanoid production: role of phospholipases and inhibitors. Bio/Technology, 1987, 5, 1294−1300.
- Dennis EA. Diversity of group types, regulation, and function of phospholipase A2. J. Biol. Chem., 1994, 269, 13 057−13 060.
- Ellis C, Moran M, McCormick F and Pawson T. Phosphorylation of GAP and GAP-associated proteins by transforming and mytogenic tyrosine kinases. Nature, 1990, 343, 377−380.
- Falcone G, Tato F and Alema S. Distinctive effects of the viral oncogenes myc, erb, fps, and src on the differentiation program of quail myogenic cells. PNAS USA, 1985, 82, 426−430.
- Fanger GR, Johnson NL, Johnson GL. MEK kinases are regulated by EGF and selectively interact with Rac/Cdc42. EMBOJ. 1997, 16(16), 4961−72.
- Fields S. and Song O. A novel genetic system to detect protein-protein interactions. Nature, 1989, 340, 245−246.
- Fornase AJ, Alamo I, Hollander MC. DNA damage-inducible transcrips in mammalian cells. Proc. Natl Acad. Sci. USA, 1988, 85, 8800−8804
- Forster S, Ilderton E, Norris JF, Summerly R and Yardley HJ. Characterization and activity of phospholipase A2 in normal human epidermis and in lesion-free epidermis of patients with psoriasis or eczema. Br. J. Dermatol, 1985, 112, 135−147
- Geiser AG, Kim SJ, Roberts AB, Sporn MB. Characterization of the mouse transforming growth factor-beta 1 promoter and activation by the Ha-ras oncogene. Mol Cell Biol, 1991, 11(1), 84−92.
- Feng GS, Pawson T. Phosphotyrosine phosphatases with SH2 domains: regulators of signal transduction. Trends Genet., 1994, 10(2), 54−58.
- Gibbs JB, Maarshall MS. The ras oncogene~an important regulatory element in lower eucaryotic organisms. Microbiol Rev., 1989, 53(2), 171−185.
- Gibbs JB. Ras C-terminal processing enzymes — new drug targets? Cell, 1991 65(1), 1−4.
- Golden A, Nemeth SP, and Brugge JS. Blood platelets express high levels of the pp60c-src-specific tyrosine kinase activity. Proc.Natl. Acad. Set USA, 1986, 853, 852−856.
- Golden A, Brugge JS, Shattil SJ. Role of platelet membrane glycoprotein Ilb-Illa in agonist-induced tyrosin phosphorylation of platelet proteins. J. Cell. Biol., 1990, 11,3117−3127.
- Grand RJ, Owen D. The biochemistry of ras p21. Biochem J., 1991, 279, 609−31.
- Fanger GR, Gerwins P, Widmann C, Jarpe MB, Johnson GL. MEKKs, GCKs, MLKs, PAKs, TAKs, and tpls: upstream regulators of the c-Jun amino-terminal kinases? Curr Opin Genet Dev, 1997, 7(1), 67−74.
- Ferrell JE, Martin GS. Tyrosine-specific protein phosphorylation is regulated by glycoprotein Ilb-IIIa in platelets. Proc.Natl. Acad. Sci. USA, 1989, 86, 2234−2238.
- Hancock JF, Cadwallader K, Marshall CJ. Methylation and proteolysis are essential for efficient membrane binding of prenylated p21K-ras (B). EMBOJ., 1991, 10(3), 641−6.
- Hancock JF, Magee Al, Childs JE, Marshall CJ. All ras proteins are polyisoprenylated but only some are palmitoylated. Cell, 1989, 57, 1167−77.
- Hancock JF, Paterson H, Marshall CJ. A polybasic domain or palmitoylation is required in addition to the CAAX motif to localize p21ras to the plasma membrane. Cell, 1990, 63, 133−139.
- Hanks SK, Quinn AM. Protein kinase catalytic domain sequence database: identification of conserved features of primary structure and classification of family members. Methods Enzymol. 1991, 200, 38−62.
- Hunter T, Sefton BM. Transforming gene product of Rous sarcoma virus phosphorylates tyrosine. Proc Natl Acad Sci USA, 1980, 77, 1311−5.
- Harddie G, Hanks S ed., The protein kinase Facts Book, Academic press London, 1998.
- Hirai H, Varmus HE. Site-directed mutagenesis of the SH2- and SH3-coding domains of c-src produces varied phenotypes, including oncogenic activation of p60c-src. Mol Cell Biol, 1990 a, 10(4), 1307−18.
- Hirai H, Varmus HE Mutations in sre homology regions 2 and 3 of activated chicken c-src that result in preferential transformation of ."mouse or chicken cells. Proc Natl Acad Sci USA, 1990 b, 87(21), 8592−6.
- Hirai H, Varmus HE SH2 mutants of c-src that are host dependent for transformation are trans-dominant inhibitors of mouse cell transformation by activated c-src. Genes Dev, 1990 c, 4, 2342−52.
- Holland J, Owens T. Signaling through intercellular adhesion molecule 1 (ICAM-1) in, Π° Π cell lymphoma line. The activation of Lyn tyrosine kinase and the mitogen-activated protein kinase pathway. J Biol Chem, 1997, 272, 9108−12.
- Hollander MC, Alamo I, Fornase AJ. A novel DNA damage-inducible transcript, gadd7, inhibits cell growth, but lacks a protein product. Nucleic Acids Research, 1996, 24, 1589−1593.
- Iba H, Cross FR, Garber EA, Hanafusa H. Low level of cellular protein phosphorylation by non-transforming overproduced p60Β°"sro. Moll. Cell. Biol., 1985, 5, 1058−66.
- Imamoto A, Soriano P. Disruption of the csk gene, encoding a negative regulator of Src family tyrosine kinases, leads to neural tube defects and eembryonic lethality in mice. Cell, 1993, 73.
- Irby RB, Mao W, Coppola D, Kang J, Loubeau JM, Trudeau W, Karl R, Fujita DJ, Jove R and Yeatman TJ. Activating SRC mutation in a subset of advanced human colon cancers. Nat Genet, 1999, 21(2), 187−90.
- Kamps MP, Sefton BM. Neither arginine nor histidine can carry out the function of lysine-295 in the ATP-binding site of p60src. Moll. Cell. Biol, 1986, 6, 751−57.
- Kamps MP, Taylor SS, Sefton BM. Direct evidence that oncogenic tyrosine kinase and cyclic AMP-dependent protein kinases have homologous ATP-binding sites. Nature, 1984, 310, 589−592.
- Kami R, Jove R, Levitzki A. Inhibition of pp60c-Src reduces Bcl-XL expression and reverses the transformed phenotype of cells overexpressing EGF and HER-2 receptors. Oncogene, 1999, 18(33), 4654−62.
- Kmiecik Π’Π, Jonson PJ, Schalloway D. Regulation by the autophosphorylation site in overexpressed pp60c-src. Moll Cell. Biol, 1988, 8, 4541−4546.
- Krasilnikov MA. Shatskaya VA. Shtutman M. Regulation of phospholipid turnover in hamster fibroblasts, transformed by oncogenes v-src and N-ras. Biochemistry (Moscow), 1995,59, 1315−1320.
- Krueger JG, Garber EA, Goldberg AR, Hanafusa H. Changes in aminoterminal sequences of p60v"src lead to decreased membrane association and decreased in vivo tumorigenicity. Cell, 1982, 28, 889−896
- Krueger JG, Wang E, Goldberg AR. Evidence that the src gene product of Rous sarcoma virus is membrane associated. Virology, 1980, 101, 25−40.
- Kypta RM, Goldberg Y, Ulug ET and Courtheidge SA. Association between the PDGF receptor and members of the src family of tyrosine kinases. Cell, 1990, 62, 481−492.
- Leto TL, Lomax KJ, Yolpp BD, Nunoi H, Sechler JM, Nauseef WM, Clark RA, Gallin JI, Malech HL. Cloning of a 67-kD neutrophil oxidase factor with similarity to a noncatalytic region of p60c-src.Science. 1990, 248, 727−30.
- Linder ME and Burr JG. Nonmyristoylated p60v-src fails to phosphorylate proteins of 115−120 kDa in chicken embryo fibroblasts. Ph’AS USA, 1988, 85, 2608−2612.
- Liu X, Marengere LE, Koch CA, Pawson T. The v-Src SH3 domain binds phosphatidylinositol 3'~kinase. Mol Cell Biol, 1993, 13,5225−32.
- Loo WM, Berestecky JM, Kanemitsu MY and Lau AF. pp60src-mediated phosphorylation of connexin 43, a gap junction protein. J Biol Chem, 1995, 270(21), 12 751−61.
- Lowenstein EJ, Daly RJ, Batzer AG, Li W, Margolis B, Lammers R, Ullrich A, Skolnik EY, Bar-Sagi D, Schlessinger J. The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell, 1992, 70(3), 431−42.
- Luban J, Goff S. The yeast two-hybrid system for studying protein-protein interactions. Curr Opin Biotechnol, 1995, 59−64.
- Machesky LM, Hall A. Role of actin polymerization and adhesion to extracellular matrix in Rac- and Rho-induced cytoskeletal reorganization. J Cell Biol. 1997,138(4), 913−26.
- Makowski L, Caspar DL, Phillips WC, Goodenoudh DA. Gap junction structures. J. Cell. Biol. 1977, 74, 629−645.
- Manser E, Loo TH, Koh CG, Zhao ZS, Chen XQ, Tan L, Tan I, Leung T, Lim L. Π ΠΠ kinases are directly coupled to the PIX family of nucleotide exchange factors. Mol Cell, 1998, 1(2), 183−92.
- Marilyn D Resh Myristylation and halmitylation of Src family members: the fats of the metter. Cell, 1994, 76, 411−413
- Marshall CJ. Ras effectors. Curr Opin Cell Biol, 1996, 8(2), 197−204.
- Marshall CJ. Cell signalling. Raf gets it together. Nature, 1996, 383, 127−8.
- Martin GS. The hunting of the Src. Nat Rev Mol Cell Biol, 2001, 2(6), 467−75.
- Mayer Π J, Hamaguchi M, Hanafusa H. A novel viral oncogene with structural similarity to phospholipase C. Nature, 1988, 332, 272−5.
- McCormick F. How receptors turn Ras on. Nature, 1993, 363, 15−16.
- Moodie SA and Wolfmann A. The 3Rs of life: Ras, Raf and growth regulation. Trends in genetics, 1994, 10, 44−48.
- Moran MF, Koch Π‘ A, Anderson D, Ellis C, England L, Martin GS, Pawson T. Src homology region 2 domains direct protein-protein interactions in signal transduction. Proc Natl Acad Sci USA, 1990, 87(21), 8622−6.
- Mukherjee, AB, MieleL, Pattabiraman N. Phospholipase A2 enzymes: regulation and physiological role. Biochem Pharmacol, 1994, 48(1), 1−10
- Nada S, Yagi T, Takeda H, Tokunaga T, Nakagawa H, Ikawa Y, Okada M, Aizawa S. Constitutive activation of Src family kinases in mouse embryos that lack Csk. Cell, 1993,73
- Nada S, Okada M, MacAuley A, Cooper JA, Nakagawa H. Cloning of a complementary DNA for a protein-tyro sine kinase «that specifically phosphorylates a negative regulatory site of p60c-src. Nature, 1991, 351, 6972.
- O’Brien MC, Fukui Y, Hanafusa HActivation of the proto-oncogene p60c-src by point mutations in the SH2 domain. Mol Cell Biol, 1990, 10(6), 2855−62.
- Okada M and Nakagawa H. A protein tyrosine kinase involved in regulation of pp60c-src function. J. Biol. Chem., 1989, 264, 200 886−20 893.
- Okada M, Nada S, Yamanashi Y, Yamamoto T, Nakagawa H. CSK: a protein-tyrosine kinase involved in regulation of src family kinases. J. Biol. Chern., 1991,266, 24 249−24 252.
- Okada M, Howell BW, Broome MA, Cooper JA. Deletion of the SH3 domain of Src interferes with regulation by the phosphorylated carboxyl-terminal tyrosine. J Biol Chem., 1993, 268(24), 18 070−5.
- Olson MF, Ashworth A, Hall A. An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through Gl. Science, 1995, 269, 1270−2
- Oppermann H, Levinson AD, Yarmus HE, Levintow L, Bishop JM. Uninfected vertebrate cells contain a protein that is closely related to the product of the avian sarcoma virus transforming gene (src). Proc Natl Acad Sci USA. 1979, 76(4), 1804−8.
- Ostermeyer AG, Anderson SM. Induction of growth factor-independence and GM-CSF secretion by the v-src oncogene in murine myeloid cells does not require membrane association of pp60v-src.Exp Hematol, 1996, 24(2), 176 184.
- Ozawa M, Ringwa M and Demler R. Uvomorulin-catenin complex formation is regulated by a specific domain in the cytoplasmic region of the cell adhesion molecule. Proc Natl Acad Sci USA, 1990, 87(11), 4246−50.
- Parsons JT and Weber MJ. Genetics of src: structure and functional organization of a protein tyrosine kinase. Curr. Top. Microbiol. Immunol., 1989, 147, 79−127.
- Patschinsky T, Hunter T, Esch FS, Cooper JA, Sefton BM. Analysis of the sequence of amino acids surrounding sites of tyrosine phosphorylation. Proc Natl Acad Sci USA, 1982, 79(4), 973−7.
- Pawson T and Gish GD. SH2 andSH3 domains: from structure to function. Cell, 1992,71,359−362.
- Pawson T. Protein modules and signalling networks. Nature, 1995, 373, 57 380.
- Penuel E and Martin GS. Transformation by v-Src: Ras-MAPK and PI3K-mTOR mediate parallel pathways. Mo I Biol Cell, 1999, 10, 1693−703.
- Purchio AF. Evidence that pp60src, the product of the Rous sarcoma virus src gene, undergoes autophosphorylation. J. Virol, 1982, 41, 1−7
- Raymond VM and Parsons JT. Identification of an amino terminal domain required for the transforming activity of the Rous sarcoma virus src protein. Virology, 1987, 160, 400−10.
- Ren R, Mayer BJ, Cicchetti P and Baltimore D. Identification of a ten-amino acid proline-rich SH3 binding site. Science, 1993, 259, 1157−1161.
- Reynolds AB, Herbert L, Cleveland JL, Berg ST and Gaat JR. pl20, a novel substrate of proteine tyrosine kinase receptors and of p60v"src is related to cadherin-binding factors P-catenin, plakoglobin and armadillo. Oncogene 1992, 7, 2439−2445.
- Rickles RJ, Botfield MC, Zhou XM, Henry PA, Brugge JS, Zoller MJ. Phage display selection of ligand residues important for Src homology 3 domain binding specificity. Proc Natl Acad Sci USA, 1995,92, 10 909−13.
- Rous P. A sarcoma of the fowl transmissible by an agent separable from the tumour cells. J. Exp. Med., 1911,13, 397−411
- Roussel RR, Brodeur SR, Shalloway D, Laudano AP Selective binding of activated pp60c-src by an immobilized synthetic phosphopeptide modeled on the carboxyl terminus of pp60c-src. Proc Natl Acad Sci USA, 1991, 88(23), 10 696−700.
- Satake M, Furukawa Π, Ito Y. Biological activities of oligonucleotides spanning the F9 point mutation within the enhancer region of polyomavirus DNA. J Virol, 1988, 62, 970−7.
- Schlaepfer DD, Hanks SK, Hunter T, Geer P. Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature, 1994, 372, 786−791.
- Schroder T, Kivilaakso E, Kinnunen PK, Lempinen M. Serum phospholipase A2 in human acute pancreatitis. Scand. J. Gastroenterol, 1980, 15, 633−636.
- Schwartzberg PL. The many faces of Src: multiple functions of a prototypical tyrosine kinase. Oncogene, 1998, 17, 1463−8.
- Sefton BM, Trowbridge IS, Cooper JA, Scolnick EM. The transforming proteins of Rous sarcoma virus, Harvey sarcoma virus and Abelson virus contain tightly bound lipid. Cell, 1982, 31, 465−74.
- Sefton BM, Hunter T, Beemon K, Eckhart W. EVidence that the phosphorylation of tyrosine is essential for cellular transformation by Rous sarcoma virus. Cell, 1980, 20, 807−816.
- Segal J. Calmodulin modulates thymocyte adenylate cyclase activity through the guanine nucleotide regulatory unit. Mol Cell Endocrinol, 1989, 64(1), 95 103.
- Shalloway D, Coussens P, Yaciuk P. Overexpression of the c-src protein does not induce transformation of NIH 3T3 cells. PNAS USA. 1984, 81, 7071−75.
- Sicheri F, Kuriyan J. Structures of Src-family tyrosine kinases. Curr Opin Struct Biol, 1997, 7, 777−85.
- Sistonen L, Holtta E, Lehvaslaiho H, Lehtola L, Alitalo K. Activation of the neu tyrosine kinase induces the fos/jun transcription factor complex, the glucose transporter and ornithine decarboxylase. J Cell Biol, 1989, 109(5), 1911−9.
- Smith MR, DeGudicibus SJ, Stacey DW. Requirement for c-ras proteins during viral oncogene transformation. Nature, 1986, 320, 540−3.
- Snyder MA, Bishop JM, McGrath JP, Levinson AD. A mutation at the ATP-binding site of pp60v"src abolilishes kinase activity, transformation, and tumorigenicity. Mol. Cell. Biol, 1985, 5, 1772−1779.
- Soriano P, Montgomery C, Geske R, and Brandley A. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell, 1991, 64, 693 702.
- Souyri MC, Koehne F, CTDonnell PV, Aldrich TH, Furth ME, Fleissner E. Biologikal Effects of a murine retrovirus carrying an activated N-ras gene of human origin. Virology, 1987, 158, 69−78.
- Stehelin D, Varmus H, Bishop J, Vogt P. DNA related to the transforming gene (s) of avian sarcoma viruses is present in normal avian DNA. Nature, 1976, 260, 170−173.
- Sten PL, Vogel H, Soriano P. Combined deficiencies of Src, fyn and Yes tyrosine kinases in mutant mice. Genes Dev, 1994, 8, 1999−2007.
- Stokoe D, McCormick F. Activation of c-Raf-1 by Ras and Src through different mechanisms: activation in vivo and in vitro. EMBO J., 1997, 16(9), 2384−96.
- Sugimoto Y, Whitman M, Cantley LC, Erikson RL Evidence that the Rous sarcoma virus transforming gene product phosphorylates phosphatidyl inositol and diacylglycerol. Proc Natl Acad Sci USA, 1984, 81(7), 2117−21.
- Superti-Furga, G, Courtneidge SA. Structure-function relationships in Src family and related protein tyrosine kinases. Bioessays, 1995, 17(4), 321−30.
- Taniguchi T. Cytokine signaling through nonreceptor protein tyrosine kinases. Science. 1995,268,251−5.
- Takekawa M, Posas F, Saito H. A human homolog of the yeast Ssk2/Ssk22 MAP kinase kinase kinases, MTK1, mediates stress-induced activation of the p38 and JNK pathways. EMBO J., 1997, 16(16), 4973−82. *
- Takey Π’., Hanafusa H. Structure and sequence of the cellular gene homologous to the RSV src gene and the mechanism for generating the transforming virus. Cell 1983, 32, 881−90.
- Tang Y, Chen Z, Ambrose D, Liu J, Gibbs JB, Chernoff J, Field J. Kinase-deficient Pakl mutants inhibit Ras transformation of Rat-1 fibroblasts. Mol Cell Biol, 1997, 17(8), 4454−64.
- Tatosyan A, Shtutman M, Topol L, Kisseljova N, Musatkina E, Deichman G. Selective integration of virus genome in high and low metastatic transformed cell lines. Modern trends in human leukemia, 1991, 9, p 235−238.
- Thomas SM, Brugge JS. Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol, 1997, 13, 513−609.
- Tischfield JA. A reassessment of the low molecular weight phospholipase A2 gene family in mammals. J Biol Chem., 1997, 272(28), 17 247−50.
- Ushiro H, Cohen S. Identification of phosphotyrosine as a product of epidermal growth factor-activated protein kinase in A-431 cell membranes. J Biol Chem, 1980, 255(18), 8363−5.
- Vadas P. Elevated plasma phospholipase A2 levels: correlation with the hemodynamic and pulmonary changes in gram-negative septic shock. J Lab Clin Med, 1984, 104(6), 873−81.
- Verderame MF, Kaplan JM, Varmus HE. A mutation in v-src that removes a single conserved residue in the SH-2 domain of pp60v-src restricts transformation in a host-dependent manner. J Virol, 1989, 63(1), 338−48.
- Vojtek AB, Hollenberg SM, Cooper JA. Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell, 1993, 74(1), 20 544.
- Wages DS, Keefer J, Rail Π’Π, Weber MJ. Mutations in the SH3 domain of the src oncogene which decrease association of phosphatidylinositol Π'-kinase activity with pp60v-src and alter cellular morphology. J Virol, 1992, 66(4), 1866−74.
- Weeks MO, Hager GL, Lowe R, Scolnick EM. Development and analysis of a transformation-defective mutant of Harvey murine sarcoma tk virus and its gene product. J Virol, 1985, 54(2), 586−97.
- West CM, Boettiger D. Selective effect of Rous sarcoma virus src gene expression on contractile protein synthesis in chick embryo myotubes. Cancer Res, 1983, 43, 2042−2048.
- Williams LT. Signal transduction by the platelet-derived growth factor receptor. Science, 1989, 243, 1564−1570.
- Kypta RM, Goldberg Y, Ulug ET, Courtheidge SA. Association between the PDGF receptor and members of the src family of tyrosine kinases. Cell, 1990, 62, 481−492.
- Willumsen BM, Norris K, Papageorge AG, Hubbert NL, Lowy DR. Harvey murine sarcoma virus p21 ras protein: biological and biochemical significance of the cysteine nearest the carboxy terminus. EMBOJ, 1984, 3(11), 2581−5.
- Willumsen BM, Papageorge AG, Hubbert N, Bekesi E, Kung HF, Lowy DR. Transforming p21 ras protein: flexibility in the major variable region linking the catalytic and membrane-anchoring domains. EMBOJ, 1985, 4(11):2893−6.
- Zheng XM, Resnick RJ, Shalloway D. A phosphotyrosine displacement mechanism for activation of Src by PTPalpha. EMBOJ, 2000, 19(5), 964−78.
- Xu W, Doshi A, Lei M, Ere MJ, Harrison SC. Crystal structures of c-Src reveal features of its autoinhibitory mechanism. Mol Cell, 1999, 3(5), 629−38.
- Xu W, Harrison SC, Eck MJ. Three-dimensional structure of the tyrosine kinase c-Src. Nature, 1997, 385, 595−602.
- Yoon H, Boettiger D. Expression of v-src alters the expression of myogenic regulatory factor genes. Oncogene, 1994, 9, 801−807.
- Yoshida H, Hagashi SI, Kunisada T, Ogawa M, Nishikawa S, Okamura H, Sudo T, Shultz LD, Nishikawa SI. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature, 1990,345,442−444.
- Yu CL, Meyer DJ, Campbell GS, Larner AC, Carter-Su C, Schwartz J, Jove R. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science, 1995, 269, 81−3.
- Yu H, Chen JK, Feng S, Dalgamo DC, Brauer AW, Schreiber SL. Structural basis for the binding of proline-rich peptides to SH3 domains. Cell, 1994, 76(5), 933−45.
- Zheng XM, Wang Y, Pallen CJ. Cell transformation and activation of ΡΡΠ±ΠΡ-sre by overexpression of a protein tyrosine phosphatase. Nature, 1992, 359, 336−339.150
- ΠΡΡΠ°ΠΆΠ°Ρ Π³Π»ΡΠ±ΠΎΠΊΡΡ Π±Π»Π°Π³ΠΎΠ΄Π°ΡΠ½ΠΎΡΡΡ ΠΌΠΎΠ΅ΠΌΡ Π½Π°ΡΡΠ½ΠΎΠΌΡ ΡΡΠΊΠΎΠ²ΠΎΠ΄ΠΈΡΠ΅Π»Ρ Π΄.Π±.Π½. Π. Π. Π’Π°ΡΠΎΡΡΠ½Ρ Π·Π° Π½Π°ΡΡΠ½ΠΎΠ΅ ΡΡΠΊΠΎΠ²ΠΎΠ΄ΡΡΠ²ΠΎ, ΠΌΠΎΡΠ°Π»ΡΠ½ΡΡ ΠΏΠΎΠ΄Π΄Π΅ΡΠΆΠΊΡ ΠΈ ΡΠ΅ΡΠΏΠ΅Π½ΠΈΠ΅ ΠΏΡΠΈ ΠΏΠΎΠ΄Π³ΠΎΡΠΎΠ²ΠΊΠ΅ ΡΡΠΎΠΉ ΡΠ°Π±ΠΎΡΡ.
- Π― Π±Π»Π°Π³ΠΎΠ΄Π°ΡΡ ΠΠΎΠΌΠ΅Π»ΡΠΊΠΎΠ²Π° Π. Π. Π·Π° Π±ΠΎΠ»ΡΡΡΡ ΠΏΠΎΠΌΠΎΡΡ Π² ΠΎΠ±ΡΡΠ΅Π½ΠΈΠΈ ΠΊΠΎΠΌΠΏΡΡΡΠ΅ΡΠ½ΡΠΌ ΠΌΠ΅ΡΠΎΠ΄Π°ΠΌ ΠΎΠ±ΡΠ°Π±ΠΎΡΠΊΠΈ Π΄Π°Π½Π½ΡΡ .